|
1
|
Chen Y, Hao J, Ma W, Tang Y, Gao C and Hao
X: Improvement in treatment and outcome of pancreatic ductal
adenocarcinoma in north China. J Gastrointest Surg. 15:1026–1034.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arlt A, Müerköster SS and Schäfer H:
Targeting apoptosis pathways in pancreatic cancer. Cancer Lett.
332:346–358. 2013. View Article : Google Scholar
|
|
3
|
Xu J, Liao X and Wong C: Downregulations
of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by
microRNA 153 induce apoptosis in a glioblastoma cell line
DBTRG-05MG. Int J Cancer. 126:1029–1035. 2010.
|
|
4
|
Xu J, Liao X, Lu N, Liu W and Wong CW:
Chromatin-modifying drugs induce miRNA-153 expression to suppress
Irs-2 in glioblastoma cell lines. Int J Cancer. 129:2527–2531.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tunca B, Tezcan G, Cecener G, Egeli U, Ak
S, Malyer H, Tumen G and Bilir A: Olea europaealeaf extract alters
microRNA expression in human glioblastoma cells. J Cancer Res Clin
Oncol. 138:1831–1844. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karsy M, Arslan E and Moy F: Current
progress on understanding microRNAs in glioblastoma multiforme.
Genes Cancer. 3:3–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao S, Deng Y, Liu Y, Chen X, Yang G, Mu
Y, Zhang D, Kang J and Wu Z: MicroRNA-153 is tumor suppressive in
glioblastoma stem cells. Mol Biol Rep. 40:2789–2798. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tezcan G, Tunca B, Bekar A, Preusser M,
Berghoff AS, Egeli U, Cecener G, Ricken G, Budak F, Taskapılıoglu
MO, et al: microRNA expression pattern modulates temozolomide
response in GBM tumors with cancer stem cells. Cell Mol Neurobiol.
34:679–692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tezcan G, Tunca B, Bekar A, Budak F, Sahin
S, Cecener G, Egeli U, Taskapılıoglu MO, Kocaeli H, Tolunay S, et
al: Olea europaea leaf extract improves the treatment response of
GBM stem cells by modulating miRNA expression. Am J Cancer Res.
4:572–590. 2014.PubMed/NCBI
|
|
10
|
Kim TH, Kim YK, Kwon Y, Heo JH, Kang H,
Kim G and An HJ: Deregulation of miR-519a, 153, and 485-5p and its
clinicopathological relevance in ovarian epithelial tumours.
Histopathology. 57:734–743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu L, Chen R, Huang S, Wu Y, Li G, Zhang
B, Liu Q, Yin D and Liang Y: miR-153 sensitized the K562 cells to
As2O3-induced apoptosis. Med Oncol. 29:243–247. 2012. View Article : Google Scholar
|
|
12
|
Xu Q, Sun Q, Zhang J, Yu J, Chen W and
Zhang Z: Downregulation of miR-153 contributes to
epithelial-mesenchymal transition and tumor metastasis in human
epithelial cancer. Carcinogenesis. 34:539–549. 2013. View Article : Google Scholar
|
|
13
|
Anaya-Ruiz M, Cebada J, Delgado-López G,
Sánchez-Vázquez ML and Pérez-Santos JL: miR-153 silencing induces
apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac J
Cancer Prev. 14:2983–2986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan Y, Du W, Wang Y, Xu C, Wang J, Zhang
Y, Wang H, Ju J, Zhao L, Wang Z, et al: Suppression of AKT
expression by miR-153 produced anti-tumor activity in lung cancer.
Int J Cancer. 136:1333–1340. 2015. View Article : Google Scholar
|
|
15
|
Shan N, Shen L, Wang J, He D and Duan C:
MiR-153 inhibits migration and invasion of human non-small-cell
lung cancer by targeting ADAM19. Biochem Biophys Res Commun.
456:385–391. 2015. View Article : Google Scholar
|
|
16
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar :
|
|
17
|
Wu Z, He B, He J and Mao X: Upregulation
of miR-153 promotes cell proliferation via downregulation of the
PTEN tumor suppressor gene in human prostate cancer. Prostate.
73:596–604. 2013. View Article : Google Scholar
|
|
18
|
Zhang L, Pickard K, Jenei V, Bullock MD,
Bruce A, Mitter R, Kelly G, Paraskeva C, Strefford J, Primrose J,
et al: miR-153 supports colorectal cancer progression via
pleiotropic effects that enhance invasion and chemotherapeutic
resistance. Cancer Res. 73:6435–6447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tu K, Zheng X, Zan X, Han S, Yao Y and Liu
Q: Evaluation of Fbxw7 expression and its correlation with the
expression of c-Myc, cyclin E and p53 in human hepatocellular
carcinoma. Hepatol Res. 42:904–910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Z, Sun J, Bai Z, Li H, He S, Chen R
and Che X: MicroRNA-153 acts as a prognostic marker in gastric
cancer and its role in cell migration and invasion. Onco Targets
Ther. 8:357–364. 2015.PubMed/NCBI
|
|
21
|
Huang Y, Guo W and Kan H: TPX2 is a
prognostic marker and contributes to growth and metastasis of human
hepatocellular carcinoma. Int J Mol Sci. 15:18148–18161. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C,
Yao Y and Liu Q: Fbxw7 is an independent prognostic marker and
induces apoptosis and growth arrest by regulating YAP abundance in
hepatocellular carcinoma. Mol Cancer. 13:1102014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y
and Liu Q: MicroRNA-130b promotes cell aggressiveness by inhibiting
peroxisome proliferator-activated receptor gamma in human
hepatocellular carcinoma. Int J Mol Sci. 15:20486–20499. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C, Yang W, Zhang J, Zheng X, Yao Y, Tu
K and Liu Q: SREBP-1 has a prognostic role and contributes to
invasion and metastasis in human hepatocellular carcinoma. Int J
Mol Sci. 15:7124–7138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Frampton AE, Giovannetti E, Jamieson NB,
Krell J, Gall TM, Stebbing J, Jiao LR and Castellano L: A microRNA
meta-signature for pancreatic ductal adenocarcinoma. Expert Rev Mol
Diagn. 14:267–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haider S, Wang J, Nagano A, Desai A,
Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T, Marshall JF,
Kocher HM, et al: A multi-gene signature predicts outcome in
patients with pancreatic ductal adenocarcinoma. Genome Med.
6:1052014. View Article : Google Scholar
|
|
27
|
Chen J, Xu H, Zou X, Wang J, Zhu Y, Chen
H, Shen B, Deng X, Zhou A, Chin YE, et al: Snail recruits Ring1B to
mediate transcriptional repression and cell migration in pancreatic
cancer cells. Cancer Res. 74:4353–4363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hotz B, Arndt M, Dullat S, Bhargava S,
Buhr HJ and Hotz HG: Epithelial to mesenchymal transition:
Expression of the regulators snail, slug, and twist in pancreatic
cancer. Clin Cancer Res. 13:4769–4776. 2007. View Article : Google Scholar : PubMed/NCBI
|
